Cargando…
Arthritis gene therapy's first death
In July 2007 a subject died while enrolled in an arthritis gene therapy trial. The study was placed on clinical hold while the circumstances surrounding this tragedy were investigated. Early in December 2007 the Food and Drug Administration removed the clinical hold, allowing the study to resume wit...
Autores principales: | Evans, Christopher H, Ghivizzani, Steven C, Robbins, Paul D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483436/ https://www.ncbi.nlm.nih.gov/pubmed/18510784 http://dx.doi.org/10.1186/ar2411 |
Ejemplares similares
-
Future of adenoviruses in the gene therapy of arthritis
por: Evans, Christopher H, et al.
Publicado: (2001) -
Gene therapy of the rheumatic diseases: 1998 to 2008
por: Evans, Christopher H, et al.
Publicado: (2009) -
Gene therapy for established murine collagen-induced arthritis by
local and systemic adenovirus-mediated delivery of interleukin-4
por: Kim, Seon Hee, et al.
Publicado: (2000) -
The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics
por: Evans, Christopher H, et al.
Publicado: (2005) -
Lessons learned from gene transfer approaches
por: Evans, Christopher H, et al.
Publicado: (1999)